Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-11
DOI
10.1038/s41467-019-10460-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
- (2018) Mélanie Le Duff et al. Cell Death & Disease
- The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
- (2017) Birgit Ritschka et al. GENES & DEVELOPMENT
- Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP
- (2017) Takuhei Yokoyama et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Census and evaluation of p53 target genes
- (2017) M Fischer ONCOGENE
- Poly(ADP-ribose) polymerase activity and inhibition in cancer
- (2017) Caleb Dulaney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers
- (2017) Johann de Bono et al. Cancer Discovery
- Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors
- (2017) David Quigley et al. Cancer Discovery
- Oncogenic senescence: a multi-functional perspective
- (2017) Darren J. Baker et al. Oncotarget
- High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
- (2017) Liqin Wang et al. Cell Reports
- Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
- (2016) Yi Zhu et al. AGING CELL
- PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations
- (2016) T. Helleday ANNALS OF ONCOLOGY
- Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype
- (2016) Nicolas Malaquin et al. EXPERIMENTAL GERONTOLOGY
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells
- (2016) Moureq Alotaibi et al. RADIATION RESEARCH
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
- (2016) Reut Yosef et al. Nature Communications
- Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines
- (2016) Hubert Fleury et al. Oncotarget
- Premature aging/senescence in cancer cells facing therapy: good or bad?
- (2015) Llilians Calvo Gonzalez et al. BIOGERONTOLOGY
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- Deciphering the Insights of Poly(ADP-Ribosylation) in Tumor Progression
- (2015) María Isabel Rodríguez et al. MEDICINAL RESEARCH REVIEWS
- Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
- (2015) Jianhui Chang et al. NATURE MEDICINE
- Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications
- (2015) See-Hyoung Park et al. Oncotarget
- DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
- (2015) Nicolas Malaquin et al. Frontiers in Genetics
- Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers
- (2014) Zhanna V Chitikova et al. CELL CYCLE
- New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
- (2014) P. Jelinic et al. MOLECULAR CANCER THERAPEUTICS
- A community computational challenge to predict the activity of pairs of compounds
- (2014) Mukesh Bansal et al. NATURE BIOTECHNOLOGY
- CHK2 kinase in the DNA damage response and beyond
- (2014) L. Zannini et al. Journal of Molecular Cell Biology
- Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning
- (2013) Mekayla Storer et al. CELL
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
- (2012) Isabelle J Létourneau et al. BMC CANCER
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis
- (2011) Marjo Huovinen et al. TOXICOLOGY IN VITRO
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion
- (2010) F. Rodier et al. JOURNAL OF CELL SCIENCE
- A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
- (2009) Eric Campeau et al. PLoS One
- Characterization of three new serous epithelial ovarian cancer cell lines
- (2008) Véronique Ouellet et al. BMC CANCER
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started